AI assistant
Sending…
TENAX THERAPEUTICS, INC. — Director's Dealing 2021
Jan 12, 2021
34835_dirs_2021-01-12_759b0459-0595-4960-857b-bd71493e0105.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TENAX THERAPEUTICS, INC. (TENX)
CIK: 0000034956
Period of Report: 2021-01-05
Reporting Person: Jebsen Michael B (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-05 | Stock option (right to buy) | $1.85 | A | 70000 | Acquired | 2031-01-05 | Common stock (70000) | Direct |
More from TENAX THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Share Issue/Capital Change
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
May 9
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22